{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_021649.3:c.5887G>A (p.G2019S)",
          "cDNA Change": {
            "transcript": "NM_021649.3",
            "ref": "G",
            "alt": "A",
            "position": "5887"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "S",
            "position": "2019"
          },
          "Description in input context": "c.5887G>A (p.G2019S)"
        },
        {
          "HGVS": "NM_021649.3:c.4861C>T (p.R1620W)",
          "cDNA Change": {
            "transcript": "NM_021649.3",
            "ref": "C",
            "alt": "T",
            "position": "4861"
          },
          "Protein Change": {
            "ref": "R",
            "alt": "W",
            "position": "1620"
          },
          "Description in input context": "c.4861C>T (p.R1620W)"
        },
        {
          "HGVS": "NM_021649.3:c.4576A>G (p.I1538T)",
          "cDNA Change": {
            "transcript": "NM_021649.3",
            "ref": "A",
            "alt": "G",
            "position": "4576"
          },
          "Protein Change": {
            "ref": "I",
            "alt": "T",
            "position": "1538"
          },
          "Description in input context": "c.4576A>G (p.I1538T)"
        },
        {
          "HGVS": "NM_021649.3:c.5334C>T (p.N1780D)",
          "cDNA Change": {
            "transcript": "NM_021649.3",
            "ref": "C",
            "alt": "T",
            "position": "5334"
          },
          "Protein Change": {
            "ref": "N",
            "alt": "D",
            "position": "1780"
          },
          "Description in input context": "c.5334C>T (p.N1780D)"
        },
        {
          "HGVS": "NM_021649.3:c.5665G>A (p.M1824V)",
          "cDNA Change": {
            "transcript": "NM_021649.3",
            "ref": "G",
            "alt": "A",
            "position": "5665"
          },
          "Protein Change": {
            "ref": "M",
            "alt": "V",
            "position": "1824"
          },
          "Description in input context": "c.5665G>A (p.M1824V)"
        },
        {
          "HGVS": "NM_021649.3:c.3476T>C (p.V1157F)",
          "cDNA Change": {
            "transcript": "NM_021649.3",
            "ref": "T",
            "alt": "C",
            "position": "3476"
          },
          "Protein Change": {
            "ref": "V",
            "alt": "F",
            "position": "1157"
          },
          "Description in input context": "c.3476T>C (p.V1157F)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0012456"
  },
  "Experiment Method": [
    {
      "Assay Method": "Western blot",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293 cells transfected with LRRK2 constructs",
        "Description": "Cells were transiently transfected with wild-type or mutant LRRK2 constructs."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_021649.3:c.5887G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Increased phosphorylation compared to wild-type."
        },
        {
          "Variant": "NM_021649.3:c.4861C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Decreased phosphorylation compared to wild-type."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed for each variant."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was analyzed in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 construct used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA with Tukey's multiple comparison test."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Phosphorylation levels within 80-120 units compared to wild-type.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Phosphorylation levels below 70 or above 130 units compared to wild-type.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Kinase activity assay",
      "Material used": {
        "Material Source": "Recombinant protein",
        "Material Name": "Purified LRRK2 proteins (wild-type and mutants)",
        "Description": "Proteins were expressed in E. coli and purified."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_021649.3:c.5887G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Increased kinase activity compared to wild-type."
        },
        {
          "Variant": "NM_021649.3:c.4861C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Reduced kinase activity compared to wild-type."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates performed for each variant."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample analyzed in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 protein used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Purified MBP (maltose-binding protein) used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA with Tukey's multiple comparison test."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Kinase activity within 80-120 units compared to wild-type.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Kinase activity below 70 or above 130 units compared to wild-type.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Cell viability assay",
      "Material used": {
        "Material Source": "Neuroblastoma cells (SH-SY5Y)",
        "Material Name": "Cells transfected with LRRK2 constructs",
        "Description": "Cells were transfected with wild-type or mutant LRRK2 and treated with MPP+."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_021649.3:c.5887G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Increased cell death compared to wild-type."
        },
        {
          "Variant": "NM_021649.3:c.4861C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Reduced cell death compared to wild-type."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates performed for each variant."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample analyzed in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Cells treated with MPP+ only used as a positive control for toxicity."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Untreated cells used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA with Tukey's multiple comparison test."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Cell viability within 80-120% compared to untreated controls.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Cell viability below 70% or above 130% compared to untreated controls.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}